Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 10/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31258154 | 0.80 | HTR3A (0.35) | SLC6A2SLC6A4SLC6A3TAAR1 | |
| SCHEMBL31258243 | 0.73 | KDM1A (0.39) | SLC6A2SLC6A4SLC6A3KCNH2TAAR1 | |
| SCHEMBL8629822 | 0.72 | TSHR (0.37) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL30954421 | 0.72 | TSHR (0.37) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31258282 | 0.71 | KDM1A (0.42) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL31258173 | 0.71 | GAA (0.41) | NPSR1 | |
| SCHEMBL27286780 | 0.70 | SLC6A2 (0.44) | SLC6A2SLC6A4SLC6A3KCNH2CYP2D6 | |
| SCHEMBL4574461 | 0.69 | KDM1A (0.41) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL14893783 | 0.68 | SLC6A2 (0.43) | SLC6A2SLC6A4SLC6A3KCNH2CYP2D6 | |
| SCHEMBL31258231 | 0.68 | HTR2C (0.48) | SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039312-A | Method for preparing medical intermediate 3-benzimidazoline coumarin pyranone derivative by catalyzing acid eutectic solvent | 南京欣久医药科技有限公司 | 2024-11-29 | — | — | CN | disclosed |